acetylcysteine has been researched along with Cerebral Hemorrhage in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, JS; Byun, J; Chung, Y; Kim, M; Lee, S; Lee, SU; Park, JC; Park, JE; Park, W | 1 |
Alin, L; Bourassa, MW; Brand, D; Carmichael, ST; Chen, Y; Colbourne, F; Coppola, G; Darley-Usmar, V; Dietrich, K; Holman, TR; Karuppagounder, SS; Kumar, A; Milne, GL; Nadeau, CA; Perry, S; Pinto, JT; Pratico, D; Ratan, RR; Sanchez, S; Wilkinson, CM | 1 |
Hsieh, CL; Lin, CH; Peng, CC; Peng, RY; Wang, HE | 1 |
Guo, Z; Guo, ZN; He, Y; Hu, Q; Matei, N; Tang, J; Tong, LS; Xu, L; Yang, P; Yang, Y; Zhang, JH | 1 |
Adams, J; Chopp, M; Elliott, PJ; Lu, M; Zhang, L; Zhang, RL; Zhang, ZG | 1 |
1 trial(s) available for acetylcysteine and Cerebral Hemorrhage
Article | Year |
---|---|
Reactive Oxygen Species Scavenger in Acute Intracerebral Hemorrhage Patients: A Multicenter, Randomized Controlled Trial.
Topics: Acetylcysteine; Adult; Cerebral Hemorrhage; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Selenium; Treatment Outcome | 2021 |
4 other study(ies) available for acetylcysteine and Cerebral Hemorrhage
Article | Year |
---|---|
N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E
Topics: Acetylcysteine; Animals; Arachidonate 5-Lipoxygenase; Cation Transport Proteins; Cell Nucleus; Cells, Cultured; Cerebral Hemorrhage; Collagenases; Cytoplasm; Dinoprostone; Disease Models, Animal; Eicosanoids; Female; Free Radical Scavengers; Glutathione; Hemin; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Stroke; Treatment Outcome | 2018 |
Gallic acid exhibits risks of inducing muscular hemorrhagic liposis and cerebral hemorrhage--its action mechanism and preventive strategy.
Topics: Acetylcysteine; Animals; Cerebral Hemorrhage; Chick Embryo; Dietary Supplements; Dose-Response Relationship, Drug; Dyslipidemias; Gallic Acid; Glutathione; Hypoxia-Inducible Factor 1, alpha Subunit; Neck Muscles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vitamin E | 2015 |
Hyperbaric Oxygen Preconditioning Attenuates Hemorrhagic Transformation Through Reactive Oxygen Species/Thioredoxin-Interacting Protein/Nod-Like Receptor Protein 3 Pathway in Hyperglycemic Middle Cerebral Artery Occlusion Rats.
Topics: Acetylcysteine; Animals; Arterial Occlusive Diseases; Brain Infarction; Carrier Proteins; Cell Cycle Proteins; Cerebral Hemorrhage; Glucose; Hyperbaric Oxygenation; Hyperglycemia; Inflammasomes; Male; Matrix Metalloproteinase 9; Middle Cerebral Artery; Prospective Studies; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Cell Surface; RNA, Small Interfering; Signal Transduction | 2016 |
Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
Topics: Acetylcysteine; Animals; Behavior, Animal; Blood Pressure; Body Weight; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Cerebral Infarction; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Intracranial Embolism; Male; Multienzyme Complexes; Neurologic Examination; Peroxidase; Proteasome Endopeptidase Complex; Rats; Rats, Wistar; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator | 2001 |